Compounds of the Month
Hot New Heterocycles
Here are just a few of the new compounds introduced this month at Adesis. Many are novel and the majority are exclusively available through Adesis. All compounds we list on our website are in stock. To see all of our new heterocycles Click here
Adesis, Inc. is a contract research organization (CRO) supporting the pharmaceutical and biopharmaceutical industry, biomaterials and catalysts industry.
The life science industry has embraced the philosophy of outsourcing reference standards (competitor's drugs), targets, scaffolds, building blocks and advanced intermediates. Outsourcing allows medicinal chemists to focus on design and assembly of new targets for pharmacological evaluation and streamlines the early stage drug discovery process. Similarly, other chemistry-based research organizations (catalysts, biomaterials and fragrances) have accepted similar modus of operendi in order to maximize cost controls, while having timely project successes.
The core foundation of Adesis, Inc. is attributed to our experienced chemists with the expertise to conduct complex multi-step synthetic sequences (typical range of 2 - 20 steps).
We hope you have enjoyed reading our Adesis newsletter. We welcome your comments.
With Best Wishes,
If you are interested in how your company can do business with Adesis or to learn more about our capabilities, please contact one of the members of our business development team.
Ronald G. Yarger, PhD
Director, Business Development
Ph. 302-261-3383; Mobile 302-358-8837
Paul Beard, MBA BS
Business Development Associate
Ph. 302-323-6314; Mobile 302-383-5918
BUY 3 GET 1 FREE
August Promotion: Buy 3 get one free
Buy 1 gram each of three catalog compounds get a 4th compound of your choice free. All three 1 gram orders must be purchased in the same transaction. Applies to compounds of equal or lesser value.
Please call Jack Church to place your order: 302-323-6305 or email firstname.lastname@example.org.
|Offer Expires: August 31st, 2011 |
Only one offer per person.